Brief: Dawnrays Pharmaceutical Says Unit Entered Into Product Cooperation Agreements To Engage Nanjing Han Xin Pharmaceutical Technology
23/09/2021 11:35
Sept 23 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd
2348.HK :
* UNIT ENTERED INTO PRODUCT COOPERATION AGREEMENTS TO ENGAGE
NANJING HAN XIN PHARMACEUTICAL TECHNOLOGY CO
* AGREEMENT FOR CARRYING OUT RESEARCH AND DEVELOPMENT OF
PHARMACEUTICAL PRODUCTS
Further company coverage: 2348.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO